Form 4: Cue Biopharma Executive Sells Shares
Insider Transaction (Form 4)
Sumita Ray, Chief Legal Compliance Officer of Cue Biopharma, Inc., sold 8,829 shares of common stock on August 13, 2026.
Summary
- Option exercise/conversion: acquired 18,196 Common Stock on August 13, 2026; holds 127,374 after (Direct).
- Open-market sale: disposed of 2,383 Common Stock at $29.37 ($69,989) on August 13, 2026; holds 124,991 after (Direct).
- Open-market sale: disposed of 6,442 Common Stock at $30.35 ($195,515) on August 13, 2026; holds 118,549 after (Direct).
- Open-market sale: disposed of 4 Common Stock at $31.13 ($125) on August 13, 2026; holds 118,545 after (Direct).
- Option exercise/conversion: disposed of 18,196 Common Stock on August 13, 2026; holds 36,393 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $265,628 of stock on the open market.
Insider Transactions
Sumita Ray — Officer (Chief Legal Compliance Officer), Other (Corporate Secretary)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-13 | Option exercise/conversion | Common Stock | 18,196 | — | — | 127,374 |
| 2026-08-13 | Open-market sale | Common Stock | 2,383 | $29 | $70.0K | 124,991 |
| 2026-08-13 | Open-market sale | Common Stock | 6,442 | $30 | $195.5K | 118,549 |
| 2026-08-13 | Open-market sale | Common Stock | 4 | $31 | $125 | 118,545 |
| 2026-08-13 | Option exercise/conversion | Common Stock | 18,196 | — | — | 36,393 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-13 | Option exercise/conversion (18,196 shares) |
| 2026-08-13 | Open-market sale (2,383 shares) |
| 2026-08-13 | Open-market sale (6,442 shares) |
| 2026-08-13 | Open-market sale (4 shares) |
| 2026-08-13 | Option exercise/conversion (18,196 shares) |
Keywords
insider transaction, Form 4, CUE, Cue Biopharma, Inc., bearish, Sumita Ray
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.